A clinical case of the new-onset bipolar affective disorder in the postcovid period
A large number of people who have had COVID-19 have developed mental symptoms and mood disorders. Anxiety and depression prevail among affective pathology. Evidence is accumulating that the Sars-CoV-2 virus can induce mania or hypomania in people with no personal psychopathological history. Some clinical, anamnestic and paraclinical patterns of new-onset mania and hypomania have been found. In cases of severe manic symptoms, it is possible to quickly assume the occurrence of bipolar affective disorder. The predominance of depressive and anxiety syndromes in the long-term disease and the presence of vivid vegetative symptoms can mask brief and syndromally incomplete episodes of hypomania, which distorts the understanding of the disease as a bipolar disorder. This article presents such a clinical case of the occurrence of bipolar affective disorder in a patient who had COVID-19 with an asymptomatic course. Approaches to rational diagnosis and treatment are discussed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:124 |
---|---|
Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 124(2024), 3 vom: 31., Seite 125-129 |
Sprache: |
Russisch |
---|
Weiterer Titel: |
Klinicheskii sluchai vpervye voznikshego v postkovidnyi period bipolyarnogo affektivnogo rasstroistva |
---|
Beteiligte Personen: |
Dmitriev, M N [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bipolar affective disorder |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.17116/jnevro2024124031125 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370194381 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370194381 | ||
003 | DE-627 | ||
005 | 20240328000601.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2024 xx |||||o 00| ||rus c | ||
024 | 7 | |a 10.17116/jnevro2024124031125 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM370194381 | ||
035 | |a (NLM)38529873 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 1 | |a Dmitriev, M N |e verfasserin |4 aut | |
245 | 1 | 2 | |a A clinical case of the new-onset bipolar affective disorder in the postcovid period |
246 | 3 | 3 | |a Klinicheskii sluchai vpervye voznikshego v postkovidnyi period bipolyarnogo affektivnogo rasstroistva |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A large number of people who have had COVID-19 have developed mental symptoms and mood disorders. Anxiety and depression prevail among affective pathology. Evidence is accumulating that the Sars-CoV-2 virus can induce mania or hypomania in people with no personal psychopathological history. Some clinical, anamnestic and paraclinical patterns of new-onset mania and hypomania have been found. In cases of severe manic symptoms, it is possible to quickly assume the occurrence of bipolar affective disorder. The predominance of depressive and anxiety syndromes in the long-term disease and the presence of vivid vegetative symptoms can mask brief and syndromally incomplete episodes of hypomania, which distorts the understanding of the disease as a bipolar disorder. This article presents such a clinical case of the occurrence of bipolar affective disorder in a patient who had COVID-19 with an asymptomatic course. Approaches to rational diagnosis and treatment are discussed | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a bipolar affective disorder | |
650 | 4 | |a depression | |
650 | 4 | |a hypomania | |
650 | 4 | |a postcovid affective disorders | |
650 | 4 | |a sertraline | |
650 | 4 | |a valproic acid | |
700 | 1 | |a Baeva, D O |e verfasserin |4 aut | |
700 | 1 | |a Slavgorodskaya, M S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 124(2024), 3 vom: 31., Seite 125-129 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
773 | 1 | 8 | |g volume:124 |g year:2024 |g number:3 |g day:31 |g pages:125-129 |
856 | 4 | 0 | |u http://dx.doi.org/10.17116/jnevro2024124031125 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 124 |j 2024 |e 3 |b 31 |h 125-129 |